ACBM (Acro Biomedical Co) EBITDA Margin %: 0.00% (As of Mar. 2026)


What is Acro Biomedical Co EBITDA Margin %?

Acro Biomedical Co ACBM EBITDA Margin % is 0.00% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 93 Diversified Financial Services companies, Acro Biomedical Co ranks worse than 1075267.74% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Acro Biomedical Co's EBITDA for the three months ended in Mar. 2026 was $-0.04 Mil. Acro Biomedical Co's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Acro Biomedical Co's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

Acro Biomedical Co  (OTCPK:ACBM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Acro Biomedical Co EBITDA Margin % Related Terms

Acro Biomedical Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Acro Biomedical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acro Biomedical Co EBITDA Margin % Chart

Acro Biomedical Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -642.24 -2,408.19 0.00 0.00 0.00

Acro Biomedical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ACBM vs RNGC, EEGI, GMZP: EBITDA Margin % Comparison

For the Shell Companies subindustry, Acro Biomedical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acro Biomedical Co EBITDA Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Acro Biomedical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's EBITDA Margin % falls into.


Acro Biomedical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Acro Biomedical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.092/0
= %

Acro Biomedical Co's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.04/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Acro Biomedical Co (ACBM) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Acro Biomedical Co and its competitors. According to the industry distribution chart, Acro Biomedical Co ranks #999999 out of 93 companies in the Diversified Financial Services industry.
Is Acro Biomedical Co's EBITDA Margin % too high?
Acro Biomedical Co's current EBITDA Margin % is 0.00%. Based on the distribution chart, Acro Biomedical Co ranks #999999 out of 93 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers.
How does Acro Biomedical Co's EBITDA Margin % compare to RNGC and EEGI?
According to the Diversified Financial Services industry distribution chart, Acro Biomedical Co ranks #999999 out of 93 companies for EBITDA Margin %. This places Acro Biomedical Co in the lower half of its industry. The industry median EBITDA Margin % is 11.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Diversified Financial Services company?
The median EBITDA Margin % among Diversified Financial Services companies is 11.75, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Acro Biomedical Co and its competitors. For the Diversified Financial Services industry, the median EBITDA Margin % is 11.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acro Biomedical Co's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Acro Biomedical Co (ACBM) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Acro Biomedical Co (ACBM), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acro Biomedical Co Business Description

Address 12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd is a shell company.